MIMIT grants funds to Arterra Bioscience developing biotechnological platform for bioactive compounds’ production, transportation and validation
The Ministry of Enterprise and Made in Italy (MIMIT) recently granted funds to Arterra Bioscience. The R&D project involved, is “Development of a biotechnological platform for production, transport and validation of the effectiveness of bioactive compounds for the cosmetic, nutraceutical and agri-food sector Plantform”. The company, founded in Naples in 2004, is listed since 2019 on the ” Euronext Growth Milan” market of the Italian Stock Exchange.
Bioactive molecules for agri-food, nutraceutical and cosmetic industrial sectors
As it was reported by Il Sole 24 Ore Radiocor Plus, the project uses plant organisms as a “biofactory” for the production of bioactive molecules with high added value and aims to develop new products. The compounds’ application could be in the agri-food, nutraceutical and cosmetic industrial sectors. Furthermore, by exploiting the skills of the university partner, it aims to develop innovative delivery systems to obtain formulations capable of transporting an active ingredient in an effective and stable way. In this way it will obtain products that meet the requirements of innovation, effectiveness, safety and sustainability which will satisfy important market needs. Arterra Bioscience is the leader of the project which will be carried out in partnership with the University of Florence – Department of Chemistry “Ugo Schiff”, classified as a research organisation, and Aethera Biotech, a company of the Cereal Docks Group, classified as a large company.
The project lasts 36 months and foresees a total subsidized cost of 5,086,070 euros, of which the share attributed to Arterra Bioscience is equal to 2,364.155 euros. The benefits –company says – “are determined in compliance with the maximum aid intensities and individual notification thresholds envisaged by the community regulations on state aid for research, development and innovation, established, respectively, by art. 25 and article 4 of Regulation (EU) no. 651/2014”.